Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berchuck

Showing results (131-140 of 191) with videos related to

Pageof 20
Sort By:
Gynecologic Oncology|October 1, 1995
Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinomaA Berchuck, C Anspach, A C Evans, et al.
Cancer Research|July 4, 1998
Mutation of the PTEN tumor suppressor gene in endometrial hyperplasiasG L Maxwell, J I Risinger, C Gumbs, et al.
American Journal of Obstetrics and Gynecology|February 11, 1992
Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-betaA Berchuck, G Rodriguez, G Olt, et al.
Cancer Research|February 15, 1995
Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor betaL J Havrilesky, J A Hurteau, R S Whitaker, et al.
Gynecologic Oncology|June 1, 1992
Ha-ras polymorphisms in epithelial ovarian cancerK O'Briant, N Chrysson, V Hunter, et al.
Current Problems in Cancer|March 1, 1996
Early ovarian cancer: a review of its genetic and biologic factors, detection, and treatmentM P Boente, T C Hamilton, A K Godwin, et al.
Hybridoma|October 28, 1998
Coexpression of the HER-2 gene product, p185HER-2, and epidermal growth factor receptor, p170EGF-R, on epithelial ovarian cancers and normal tissuesR C Bast, L Pusztai, B J Kerns, et al.
Molecular Carcinogenesis|November 1, 1996
Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancerJ M Lancaster, H A Brownlee, D A Bell, et al.
Gynecologic Oncology|August 12, 1998
Suppression of diacylglycerol levels by antibodies reactive with the c-erbB-2 (HER-2/neu) gene product p185c-erbB-2 in breast and ovarian cancer cell linesM P Boente, A Berchuck, R S Whitaker, et al.
American Journal of Obstetrics and Gynecology|September 1, 1993
Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasiasM F Kohler, H Nishii, P A Humphrey, et al.
Pageof 20

Showing results (131-140 of 191) with videos related to

Sort By:
Pageof 20
Gynecologic Oncology|October 1, 1995
Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinomaA Berchuck, C Anspach, A C Evans, et al.
Cancer Research|July 4, 1998
Mutation of the PTEN tumor suppressor gene in endometrial hyperplasiasG L Maxwell, J I Risinger, C Gumbs, et al.
American Journal of Obstetrics and Gynecology|February 11, 1992
Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-betaA Berchuck, G Rodriguez, G Olt, et al.
Cancer Research|February 15, 1995
Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor betaL J Havrilesky, J A Hurteau, R S Whitaker, et al.
Gynecologic Oncology|June 1, 1992
Ha-ras polymorphisms in epithelial ovarian cancerK O'Briant, N Chrysson, V Hunter, et al.
Current Problems in Cancer|March 1, 1996
Early ovarian cancer: a review of its genetic and biologic factors, detection, and treatmentM P Boente, T C Hamilton, A K Godwin, et al.
Hybridoma|October 28, 1998
Coexpression of the HER-2 gene product, p185HER-2, and epidermal growth factor receptor, p170EGF-R, on epithelial ovarian cancers and normal tissuesR C Bast, L Pusztai, B J Kerns, et al.
Molecular Carcinogenesis|November 1, 1996
Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancerJ M Lancaster, H A Brownlee, D A Bell, et al.
Gynecologic Oncology|August 12, 1998
Suppression of diacylglycerol levels by antibodies reactive with the c-erbB-2 (HER-2/neu) gene product p185c-erbB-2 in breast and ovarian cancer cell linesM P Boente, A Berchuck, R S Whitaker, et al.
American Journal of Obstetrics and Gynecology|September 1, 1993
Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasiasM F Kohler, H Nishii, P A Humphrey, et al.
Pageof 20